Cargando…
Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data
Ventilator-associated pneumonia (VAP) occurs more than 48h after mechanical ventilation and is associated with a high mortality rate. The current hospital-based study aims to investigate the association between VAP rate, incidence of bacteremia from multidrug-resistant (MDR) pathogens, and infection...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405435/ https://www.ncbi.nlm.nih.gov/pubmed/36009998 http://dx.doi.org/10.3390/antibiotics11081128 |
_version_ | 1784773880375672832 |
---|---|
author | Papanikolopoulou, Amalia Maltezou, Helena C. Stoupis, Athina Pangalis, Anastasia Kouroumpetsis, Christos Chronopoulou, Genovefa Kalofissoudis, Yannis Kostares, Evangelos Boufidou, Fotini Karalexi, Maria Koumaki, Vasiliki Pantazis, Nikos Tsakris, Athanasios Kantzanou, Maria |
author_facet | Papanikolopoulou, Amalia Maltezou, Helena C. Stoupis, Athina Pangalis, Anastasia Kouroumpetsis, Christos Chronopoulou, Genovefa Kalofissoudis, Yannis Kostares, Evangelos Boufidou, Fotini Karalexi, Maria Koumaki, Vasiliki Pantazis, Nikos Tsakris, Athanasios Kantzanou, Maria |
author_sort | Papanikolopoulou, Amalia |
collection | PubMed |
description | Ventilator-associated pneumonia (VAP) occurs more than 48h after mechanical ventilation and is associated with a high mortality rate. The current hospital-based study aims to investigate the association between VAP rate, incidence of bacteremia from multidrug-resistant (MDR) pathogens, and infection control interventions in a single case mix ICU from 2013 to 2018. Methods: The following monthly indices were analyzed: (1) VAP rate; (2) use of hand hygiene disinfectants; (3) isolation rate of patients with MDR bacteria; and (4) incidence of bacteremia/1000 patient-days (total cases, total carbapenem-resistant cases, and carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae cases separately). Results: Time trends of infection control interventions showed increased rates in isolation of patients with MDR pathogens (p <0.001) and consumption of hand disinfectant solutions (p =0.001). The last four years of the study an annual decrease of VAP rate by 35.12% (95% CI: −53.52 to −9.41; p =0.01) was recorded, which significantly correlated not only with reduced trauma and cardiothoracic surgery patients (IRR:2.49; 95% CI: 2.09–2.96; p <0.001), but also with increased isolation rate of patients with MDR pathogens (IRR: 0.52; 95% CI: 0.27–0.99; p = 0.048), and hand disinfectants use (IRR: 0.40; 95% CI: 0.18–0.89; p =0.024). Conclusions: Infection control interventions significantly contributed to the decrease of VAP rate. Constant infection control stewardship has a stable time-effect and guides evidence-based decisions. |
format | Online Article Text |
id | pubmed-9405435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94054352022-08-26 Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data Papanikolopoulou, Amalia Maltezou, Helena C. Stoupis, Athina Pangalis, Anastasia Kouroumpetsis, Christos Chronopoulou, Genovefa Kalofissoudis, Yannis Kostares, Evangelos Boufidou, Fotini Karalexi, Maria Koumaki, Vasiliki Pantazis, Nikos Tsakris, Athanasios Kantzanou, Maria Antibiotics (Basel) Article Ventilator-associated pneumonia (VAP) occurs more than 48h after mechanical ventilation and is associated with a high mortality rate. The current hospital-based study aims to investigate the association between VAP rate, incidence of bacteremia from multidrug-resistant (MDR) pathogens, and infection control interventions in a single case mix ICU from 2013 to 2018. Methods: The following monthly indices were analyzed: (1) VAP rate; (2) use of hand hygiene disinfectants; (3) isolation rate of patients with MDR bacteria; and (4) incidence of bacteremia/1000 patient-days (total cases, total carbapenem-resistant cases, and carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae cases separately). Results: Time trends of infection control interventions showed increased rates in isolation of patients with MDR pathogens (p <0.001) and consumption of hand disinfectant solutions (p =0.001). The last four years of the study an annual decrease of VAP rate by 35.12% (95% CI: −53.52 to −9.41; p =0.01) was recorded, which significantly correlated not only with reduced trauma and cardiothoracic surgery patients (IRR:2.49; 95% CI: 2.09–2.96; p <0.001), but also with increased isolation rate of patients with MDR pathogens (IRR: 0.52; 95% CI: 0.27–0.99; p = 0.048), and hand disinfectants use (IRR: 0.40; 95% CI: 0.18–0.89; p =0.024). Conclusions: Infection control interventions significantly contributed to the decrease of VAP rate. Constant infection control stewardship has a stable time-effect and guides evidence-based decisions. MDPI 2022-08-19 /pmc/articles/PMC9405435/ /pubmed/36009998 http://dx.doi.org/10.3390/antibiotics11081128 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Papanikolopoulou, Amalia Maltezou, Helena C. Stoupis, Athina Pangalis, Anastasia Kouroumpetsis, Christos Chronopoulou, Genovefa Kalofissoudis, Yannis Kostares, Evangelos Boufidou, Fotini Karalexi, Maria Koumaki, Vasiliki Pantazis, Nikos Tsakris, Athanasios Kantzanou, Maria Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title | Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title_full | Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title_fullStr | Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title_full_unstemmed | Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title_short | Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data |
title_sort | ventilator-associated pneumonia, multidrug-resistant bacteremia and infection control interventions in an intensive care unit: analysis of six-year time-series data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405435/ https://www.ncbi.nlm.nih.gov/pubmed/36009998 http://dx.doi.org/10.3390/antibiotics11081128 |
work_keys_str_mv | AT papanikolopoulouamalia ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT maltezouhelenac ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT stoupisathina ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT pangalisanastasia ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT kouroumpetsischristos ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT chronopoulougenovefa ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT kalofissoudisyannis ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT kostaresevangelos ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT boufidoufotini ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT karaleximaria ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT koumakivasiliki ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT pantazisnikos ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT tsakrisathanasios ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata AT kantzanoumaria ventilatorassociatedpneumoniamultidrugresistantbacteremiaandinfectioncontrolinterventionsinanintensivecareunitanalysisofsixyeartimeseriesdata |